Project description:Interventions: Gold Standard:;Index test:
Primary outcome(s): concentration of cell-free DNA in plasma;integrity of cell-free DNA in plasma
Study Design: Diagnostic test: case-control
Project description:Dataset consisting of sequence data from 36 glioma patients. Data includes;
-Whole exome sequencing of tumour tissue and matched germline
-Shallow whole genome sequencing of urine cell-free DNA
-Targeted capture sequencing of plasma and CSF cell-free DNA
Additional sequencing data are provided from non-glioma and healthy controls
| EGAD00001006156 | EGA
Project description:Detection of Pneumonia Pathogens from Plasma Cell-Free DNA
| PRJNA525157 | ENA
Project description:Bisulfite sequencing cell free DNA mouse
Project description:The dataset for the study "Early ctDNA molecular response captures therapeutic response in the first stage of CCTG BR.36 ctDNA-directed, multi-center phase II study of molecular response adaptive immunotherapy in non-small cell lung cancer", includes 134 bam files from hybrid capture targeted error-correction next-generation sequencing (PGDx Elio plasma resolve) from plasma cell-free DNA and matched white blood cell DNA from 35 individuals with non-small cell lung cancer on the BR.36 trial, alongside 11 bam files from targeted next generation sequencing (PGDx Elio tissue complete) of tumor DNA from 11 individuals with non-small cell lung cancer on the BR.36 trial.